Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study

被引:11
|
作者
Wan, Kim Sui [1 ,2 ]
Moy, Foong Ming [1 ]
Mohd Yusof, Khalijah [2 ,4 ]
Mustapha, Feisul Idzwan [3 ]
Mohd Ali, Zainudin [2 ]
Hairi, Noran Naqiah [1 ]
机构
[1] Univ Malaya, Fac Med, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia
[2] State Hlth Dept Negeri Sembilan, Seremban, Malaysia
[3] Minist Hlth, Dis Control Div, Putrajaya, Malaysia
[4] State Hlth Dept Johor, Johor Baharu, Malaysia
来源
PLOS ONE | 2020年 / 15卷 / 10期
关键词
TREATMENT INTENSIFICATION; THERAPY; PEOPLE; HYPERGLYCEMIA; ADHERENCE;
D O I
10.1371/journal.pone.0240531
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Clinical inertia can lead to poor glycemic control among type 2 diabetes patients. However, there is paucity of information on clinical inertia in low- and middle-income countries including Malaysia. This study aimed to determine the time to treatment intensification among T2D patients with HbA1c of >= 7% (>= 53 mmol/mol) in Malaysian public health clinics. The proportion of patients with treatment intensification and its associated factors were also determined. Material and methods This was a five-year retrospective open cohort study using secondary data from the National Diabetes Registry. The study setting was all public health clinics (n = 47) in the state of Negeri Sembilan, Malaysia. Time to treatment intensification was defined as the number of years from the index year until the addition of another oral antidiabetic drug or initiation of insulin. Life table survival analysis based on best-worst case scenarios was used to determine the time to treatment intensification. Discrete-time proportional hazards model was fitted for the factors associated with treatment intensification. Results The mean follow-up duration was 2.6 (SD 1.1) years. Of 7,646 patients, the median time to treatment intensification was 1.29 years (15.5 months), 1.58 years (19.0 months) and 2.32 years (27.8 months) under the best-, average- and worst-case scenarios respectively. The proportion of patients with treatment intensification was 45.4% (95% CI: 44.2-46.5), of which 34.6% occurred only after one year. Younger adults, overweight, obesity, use of antiplatelet medications and poorer HbA1c were positively associated with treatment intensification. Patients treated with more oral antidiabetics were less likely to have treatment intensification. Conclusion Clinical inertia is present in the management of T2D patients in Malaysian public health clinics. We recommend further studies in lower- and middle-income countries to explore its causes so that targeted strategies can be developed to address this issue.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Association of vaccine stockout with immunisation coverage in low-income and middle-income countries: a retrospective cohort study
    Lee, Donghoon
    Lavayen, Manuel Celestino
    Kim, Taeksoo Ted
    Legins, Ken
    Seidel, Michelle
    BMJ OPEN, 2023, 13 (07):
  • [32] Clinical-epidemiological characterization of cervical cancer in a middle-income country
    Morquecho, Walter
    Arguello, Mario
    Luis Reyes, Jose
    Emiliano Pulla, Fausto
    Hugo Avila, Victor
    Paola Estrada, Lorena
    Paulson, Guillermo
    Santacruz, Mayra
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Diabetes is associated with a higher risk of mortality among women in a middle-income country: Results form the Mexican Teacher's cohort study
    Lozano-Esparza, S.
    Lopez-Ridaura, R.
    Ortiz-Panozo, E.
    Gonzalez-Villalpando, C.
    Aguilar-Salinas, C.
    Hernandez-Avila, J. E.
    Hernandez-Avila, M.
    Lajous, M.
    DIABETES & METABOLISM, 2020, 46 (04) : 304 - 310
  • [34] Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review
    Sherifali, Diana
    da Silva, Lilian Pinto
    Dewan, Pooja
    Cader, F. Aaysha
    Dakhil, Zainab
    Gyawali, Bishal
    Klassen, Sheila
    Yaseen, Israa Fadhil
    Jovkovic, Milos
    Khalid, Saira
    Fitzpatrick-Lewis, Donna
    Alliston, Paige
    Racey, Megan
    GLOBAL HEART, 2024, 19 (01)
  • [35] MEDICATION ADHERENCE IN LOW INCOME ELDERLY TYPE 2 DIABETES PATIENTS: A RETROSPECTIVE COHORT STUDY
    Patel, I
    Chang, J.
    Shenolikar, R. A.
    Balkrishnan, R.
    VALUE IN HEALTH, 2009, 12 (07) : A409 - A409
  • [36] Clinical inertia on insulin treatment intensification in type 2 diabetes mellitus patients of a tertiary public diabetes center with limited pharmacologic armamentarium from an upper-middle income country
    Alvarenga, Marcelo Alves
    Komatsu, William Ricardo
    de Sa, Joao Roberto
    Chacra, Antonio Roberto
    Dib, Sergio Atala
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [37] Clinical inertia on insulin treatment intensification in type 2 diabetes mellitus patients of a tertiary public diabetes center with limited pharmacologic armamentarium from an upper-middle income country
    Marcelo Alves Alvarenga
    William Ricardo Komatsu
    Joao Roberto de Sa
    Antonio Roberto Chacra
    Sergio Atala Dib
    Diabetology & Metabolic Syndrome, 10
  • [38] Depression and type 2 diabetes in low- and middle-income countries: A systematic review
    Mendenhall, Emily
    Norris, Shane A.
    Shidhaye, Rahul
    Prabhakaran, Dorairaj
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) : 276 - 285
  • [39] Journey of medication reconciliation compliance in a lower middle-income country: a retrospective chart review
    Fatima, Samar
    Arshad, Ainan
    Zafar, Amara
    Farrukh, Sana
    Rahim, Anum
    Nazar, Saharish
    Zafar, Hasnain
    BMJ OPEN QUALITY, 2024, 13 (02)
  • [40] Severe Pediatric TBI Management in a Middle-Income Country and a High-Income Country: A Comparative Assessment of Two Centers
    Arango, Jorge, I
    George, Laeth
    Griswold, Dylan P.
    Johnson, Erica D.
    Suarez, Maria N.
    Caquimbo, Laura D.
    Molano, Milton
    Echeverri, Raul A.
    Rubiano, Andres M.
    Adelson, P. David
    FRONTIERS IN SURGERY, 2021, 8